Kheiron Medical Technologies
Latest round
- Series A
Last raised
- Jun 2019
Total raised
- $25M
Investors
- 7
About Kheiron Medical Technologies
Founded in 2016 in London, UK, Kheiron Medical Technologies develops innovative AI technologies aimed at enhancing breast cancer screening. The company has undergone strategic development, leading to its acquisition by DeepHealth in October 2024, which aims to expand AI-powered diagnostic solutions in Europe. The co-founders, Peter Kecskemethy and Tobias Rijken, have a background in healthcare technology, and Peter Kecskemethy serves as the CEO.Kheiron Medical Technologies primarily offers its flagship product, Mia, an AI platform designed to aid in breast cancer screening. Mia analyzes mammographic images to assist radiologists in determining whether a patient requires further testing, significantly improving cancer detection rates by 13% compared to traditional methods.9.The acquisition by DeepHealth enables Kheiron Medical Technologies to expand its portfolio of AI diagnostic solutions. The acquisition, finalized on October 22, 2024, aims to accelerate the introduction of breast cancer solutions across Europe. Future growth strategies include launching new AI products and targeting expansions into specific markets, further enhancing Kheiron's reach and impact.
Who invested in Kheiron Medical Technologies
7 investors across 3 rounds
See all investors in Kheiron Medical Technologies
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Kheiron Medical Technologies
Who invested in Kheiron Medical Technologies?
Kheiron Medical Technologies has 7 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Kheiron Medical Technologies raised?
Kheiron Medical Technologies has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Kheiron Medical Technologies last raise money?
Kheiron Medical Technologies's most recent round on record is a Series A, in Jun 2019.
What does Kheiron Medical Technologies do?
Founded in 2016 in London, UK, Kheiron Medical Technologies develops innovative AI technologies aimed at enhancing breast cancer screening.
Where is Kheiron Medical Technologies headquartered?
Kheiron Medical Technologies is headquartered in London, UK.
Which VCs invest in companies like Kheiron Medical Technologies?
Among active investors with capital left to deploy, Index Ventures, European Investment Bank, Highland Europe and Balderton Capital back software companies at Kheiron Medical Technologies's stage. Their profiles are linked below.
VCs backing software startups at Series A
Raising like Kheiron Medical Technologies? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.